Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

Homepage Forums RDA COVID-19 Main Forum RDA COVID-19 Posts RDA COVID-19 Recommendations and Guidelines – 5th release – PUBLISHED RDA COVID-19 Recommendations and Guidelines – 5th release -…

#90602

RDA Admin
Administrator

Dear Colleagues,
The 5th (pre-final) release is now public, and open for public comment until 8 June 2020 (https://doi.org/10.15497/rda00046) .
Please note that, in addition to the overarching RDA-COVID19-WG release, there is also a standalone RDA-COVID19-Epidemiology-WG supporting document (https://doi.org/10.15497/rda00049).
Thank you so much once again for your updates, new sections, etc. and tireless efforts to generate a meaningful, actionable, and useful document for the target audiences.
Cheers,
Claire
co-Moderator
Claire Austin
– Show quoted text -From: ***@***.***-groups.org on behalf of Hilary Hanahoe via RDA-COVID19
Sent: May 28, 2020 4:59 PM
To: ***@***.***-groups.org ; RDA COVID19 Coordination
Subject: [rda-covid19][rdacovid19-coordination] RDA COVID-19 Recommendations and Guidelines – 5th release – PUBLISHED
Dear COVID-19 Working Group Members,
We have just published the 5th (pre final) release of the COVID-19 Recommendations and Guidelines – https://doi.org/10.15497/rda00046
This version is now open for public comment until 8 June 2020
I would ask you all to circulate this document and the executive summary and press release to your networks (links below). In addition to collecting feedback on this before it is officially endorsed, we want to broadcast far and wide this amazing community collaboration, cooperation and co creation for the benefit of the stakeholders.
Though our work is not done, this release is a significant milestone. It is a culmination of thousands and thousands of hours volunteer effort from experts across many disciplines. It is the fruit of an unbelievable drive and demonstration of passion and dedication from a global RDA community. A community I am so proud to represent.
I would like to thank you all so much for responding to the call for action less than 2 months ago. Please allow me to thank especially the co-chairs, moderators and the editorial team whose energy and tireless efforts have amazed and astounded me over this intense period.
My sincerest gratitude to you all
Hilary
News piece and press content at https://www.rd-alliance.org/global-research-data-alliance-community-resp
1. Research Data Alliance COVID-19 Recommendations and Guidelines Executive Summary
2. Research Data Alliance COVID-19 Complete Recommendations and Guidelines – 28 May 2020 Release
3. RDA COVID-19 Working Group
4. RDA COVID-19 All Working Group Outputs (5 releases)
_____________________________________
Hilary Hanahoe
Secretary General Research Data Alliance
Tel: +39-345-4719284
email: ***@***.***-foundation.org
skype: hilary.hanahoe
Twitter: @hilaryhanahoe
Orcid ID: 0000-0002-0328-3419
Web: http://www.rd-alliance.org
RDA Foundation: https://www.rd-alliance.org/about-rda/rda-foundation
_____________________________________
RDA 16th Plenary Meeting, 10 – 12 November 2020, San Jose, Costa Rica – see updates
RDA 17th Plenary Meeting, 20 -22 April 2021, Edinburgh, Scotland – see updates
IDW2021 (co-organised by RDA, CODATA and WDS and incorporates 18th RDA Plenary Meeting), 8-11 November 2021, Seoul, Republic of Korea – see updates
_____________________________________
The information contained in this message and any attachments are intended solely for the attention and use of the named addressee and may be confidential. If you are not the intended recipient, you are reminded that the information remains the property of the sender. You must not use, disclose, distribute, copy, print or rely on this e-mail. If you have received this message in error, please contact the sender immediately and irrevocably delete or destroy this message and any copies.

Homepage